Ann: VitroGro Sales Planned to Start in June 2012, page-21

re: Ann: VitroGro Sales Planned to Start in J... When I read the announcment, I interpreted that there was a forced delay of two months due to:-

“This data has not traditionally been required for the approval and reimbursement of wound
care products and Tissue Therapies is one of very few wound care companies that can
supply all of this.”

Perhaps it could have been rewritten to finish with .... "one of the few companies that were forced to supply all of this"

TIS have not been outstanding at deadlines or communication. I therefore interpreted the expiry dates blurb as a means of covering management with a silly excuse and labelling it as a "Deferral". I am not convinced from the wording that the "Deferral" was strategic.

I see the financial risks for the company as Quintiles sales and marketing staff lying idle. Surely you can't hire staff and leave them idle for months and surely job offers can't be left for months without paying these staff.

I am not a downramper as like resourced I hold so many shares.